R. Maisano

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study

A. Mafodda, Dario Giuffrida, Angela Prestifilippo et al. · Supportive Care in Cancer · 2017 · 53 citations · Full text

Medicine, Hematology, Pharmacology +17

Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)

Stefano Cascinu, Francesco Graziano, Francesco Ferraù et al. · Annals of Oncology · 2002 · 52 citations · Full text

Medicine, Oncology, Chemotherapy +11

Mucinous histology of colon cancer predicts poor outcomes with FOLFOX regimen in metastatic colon cancer

R. Maisano, D. Azzarello, Maurizio Maisano et al. · Journal of Chemotherapy · 2012 · 51 citations

Medicine, Oncology, Pathology +17

Carboplatin and Gemcitabine Combination in Metastatic Triple-Negative Anthracycline- and Taxane-Pretreated Breast Cancer Patients: A Phase II Study

R. Maisano, M. Zavettieri, D. Azzarello et al. · Journal of Chemotherapy · 2011 · 37 citations

Medicine, Pharmacology, Breast Oncology +16